Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 12/20 | 0.51 |
| ▸ | CA9 | Q16790 | 9/20 | 0.51 |
| ▸ | CA12 | O43570 | 7/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.50 |
| ▸ | PIK3CA | P42336 | 3/20 | 0.49 |
| ▸ | MTOR | P42345 | 2/20 | 0.49 |
| ▸ | MAP3K14 | Q99558 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 8/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.43 |
| ▸ | CDK2 | P24941 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15756919 | 0.86 | KCNH2 (0.67) | KCNH2PIK3CAMTORMAP3K14PTGS2 | |
| SCHEMBL30218036 | 0.81 | CA2 (0.50) | CA2CA9CA12KCNH2PIK3CA | |
| SCHEMBL15756786 | 0.77 | FLT3 (0.59) | PIK3CAMTORMAP3K14 | |
| SCHEMBL15288131 | 0.77 | FYN (0.55) | KCNH2PIK3CAMTORMAP3K14 | |
| SCHEMBL21084307 | 0.77 | TGFBR1 (0.47) | CA2CA9CA12PIK3CAMTOR | |
| SCHEMBL26178953 | 0.77 | KDR (0.53) | KCNH2PIK3CAMTORMAP3K14 | |
| SCHEMBL3846712 | 0.77 | MKNK1 (0.61) | PIK3CAMTORMAP3K14 | |
| SCHEMBL15756965 | 0.77 | MAP3K14 (0.54) | KCNH2PIK3CAMTORMAP3K14 | |
| SCHEMBL14852149 | 0.77 | PIK3CA (0.48) | KCNH2PIK3CAMTORMAP3K14 | |
| SCHEMBL3847512 | 0.75 | MKNK1 (0.51) | PIK3CAMTORMAP3K14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2048142-A2 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | Eisai R&D Management Co., Ltd. (JP) | 2009-04-15 | — | — | EP | disclosed |
| EP-1382603-B1 | NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | EISAI R&D MAN CO LTD (JP) | 2008-07-23 | — | — | EP | disclosed |
| US-7074801-B1 | Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof | EISAI CO., LTD. (JP) | 2006-07-11 | — | — | US | disclosed |
| EP-1382603-A1 | NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF | Eisai Co., Ltd. (JP) | 2004-01-21 | — | — | EP | disclosed |